特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖モニタリングシステム:世界市場の展望(2019年~2027年)

Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)

発行 Stratistics Market Research Consulting 商品コード 947072
出版日 ページ情報 英文 175 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
血糖モニタリングシステム:世界市場の展望(2019年~2027年) Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)
出版日: 2020年07月01日 ページ情報: 英文 175 Pages
概要

世界の血糖モニタリングシステム市場は、2019年に94億5,000万米ドルとなりました。同市場は、予測期間中に6.3%のCAGRで成長する見通しで、2027年には154億1,000万米ドルに達すると予測されています。製品の発売数の増加や、糖尿病の有病率増加は、同市場の成長を促進する主な要因です。ただし、厳しい規制やラボへの投資減額などの要因は、市場成長の妨げとなっています。

当レポートは世界の血糖モニタリングシステム市場について調査しており、市場機会や動向、成長および抑制要因、タイプ・モダリティ・流通チャネル・デバイス・テストサイト・看護環境・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 成長要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 用途分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界市場:タイプ別

  • 非侵襲的
  • 侵襲的

第6章 世界市場:モダリティ別

  • 非ウェアラブル
  • ウェアラブル

第7章 世界市場:流通チャネル別

  • 小売
  • 機関

第8章 世界市場:デバイス別

  • 血糖モニタリングシステムの自己モニタリング
    • 血糖値計
    • ランセット・ランシングデバイス
    • テストストリップ
  • 連続血糖モニタリングシステム
    • 受信機
    • センサー
    • 送信機

第9章 世界市場:テストサイト別

  • 代替サイトテスト
  • 指先テスト

第10章 世界市場:看護環境別

  • 病院・クリニック
  • セルフ/ホームケア

第11章 世界市場:用途別

  • 妊娠糖尿病
  • 糖尿病
    • 1型糖尿病
    • 2型糖尿病

第12章 世界市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第13章 主な発展

  • 契約、提携、協業、合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の主な戦略

第14章 企業プロファイル

  • Abbott
  • Ascensia Diabetes Care Holdings AG
  • Braun Melsungen AG
  • Dexcom, Inc.
  • DiamonTech GmbH
  • Hoffmann-La Roche Ltd.
  • Lifescan Inc.
  • Medtronic
  • テルモ株式会社
  • Ypsomed
  • ニプロ株式会社
  • Sanofi
  • Arkray
  • Acon Laboratories
  • Prodigy Diabetes Care
図表

List of Tables

  • Table 1 Global Blood Glucose Monitoring Systems Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Blood Glucose Monitoring Systems Market Outlook, By Type (2018-2027) ($MN)
  • Table 3 Global Blood Glucose Monitoring Systems Market Outlook, By Non-Invasive (2018-2027) ($MN)
  • Table 4 Global Blood Glucose Monitoring Systems Market Outlook, By Invasive (2018-2027) ($MN)
  • Table 5 Global Blood Glucose Monitoring Systems Market Outlook, By Modality (2018-2027) ($MN)
  • Table 6 Global Blood Glucose Monitoring Systems Market Outlook, By Non- Wearable (2018-2027) ($MN)
  • Table 7 Global Blood Glucose Monitoring Systems Market Outlook, By Wearable (2018-2027) ($MN)
  • Table 8 Global Blood Glucose Monitoring Systems Market Outlook, By Distribution Channel (2018-2027) ($MN)
  • Table 9 Global Blood Glucose Monitoring Systems Market Outlook, By Retail Sales (2018-2027) ($MN)
  • Table 10 Global Blood Glucose Monitoring Systems Market Outlook, By Institutional Sales (2018-2027) ($MN)
  • Table 11 Global Blood Glucose Monitoring Systems Market Outlook, By Device (2018-2027) ($MN)
  • Table 12 Global Blood Glucose Monitoring Systems Market Outlook, By Self-monitoring of Blood Glucose Monitoring Systems (2018-2027) ($MN)
  • Table 13 Global Blood Glucose Monitoring Systems Market Outlook, By Blood Glucose meters (2018-2027) ($MN)
  • Table 14 Global Blood Glucose Monitoring Systems Market Outlook, By Lancets & Lancing Devices (2018-2027) ($MN)
  • Table 15 Global Blood Glucose Monitoring Systems Market Outlook, By Testing strips (2018-2027) ($MN)
  • Table 16 Global Blood Glucose Monitoring Systems Market Outlook, By Continuous Blood Glucose Monitoring Systems (2018-2027) ($MN)
  • Table 17 Global Blood Glucose Monitoring Systems Market Outlook, By Receivers (2018-2027) ($MN)
  • Table 18 Global Blood Glucose Monitoring Systems Market Outlook, By Sensors (2018-2027) ($MN)
  • Table 19 Global Blood Glucose Monitoring Systems Market Outlook, By Transmitters (2018-2027) ($MN)
  • Table 20 Global Blood Glucose Monitoring Systems Market Outlook, By Testing Site (2018-2027) ($MN)
  • Table 21 Global Blood Glucose Monitoring Systems Market Outlook, By Alternate Site Testing (2018-2027) ($MN)
  • Table 22 Global Blood Glucose Monitoring Systems Market Outlook, By Fingertip testing (2018-2027) ($MN)
  • Table 23 Global Blood Glucose Monitoring Systems Market Outlook, By Patient Care Setting (2018-2027) ($MN)
  • Table 24 Global Blood Glucose Monitoring Systems Market Outlook, By Hospital & Clinics (2018-2027) ($MN)
  • Table 25 Global Blood Glucose Monitoring Systems Market Outlook, By Self/Home Care (2018-2027) ($MN)
  • Table 26 Global Blood Glucose Monitoring Systems Market Outlook, By Application (2018-2027) ($MN)
  • Table 27 Global Blood Glucose Monitoring Systems Market Outlook, By Gestational Diabetes (2018-2027) ($MN)
  • Table 28 Global Blood Glucose Monitoring Systems Market Outlook, By Diabetes (2018-2027) ($MN)
  • Table 29 Global Blood Glucose Monitoring Systems Market Outlook, By Type 1 Diabetes (2018-2027) ($MN)
  • Table 30 Global Blood Glucose Monitoring Systems Market Outlook, By Type 2 Diabetes (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次

According to Stratistics MRC, the Global Blood Glucose Monitoring Systems Market is accounted for $9.45 billion in 2019 and is expected to reach $15.41 billion by 2027 growing at a CAGR of 6.3% during the forecast period. Increasing number of product launches and increasing prevalence of diabetes are the major factors propelling the market growth. However, factors such as strict regulations and decreased lab investments are hampering the market growth.

Blood glucose monitoring systems are diagnostics systems that are very essential for the care and treatment of diabetes, it is used to measure and monitor the levels of blood sugar in the patients. The significance of blood glucose monitoring system's command is very high, with the growing prevalence of diabetes and diabetic population across the regions. These systems usually take blood samples, but with rising innovation and advancements in technology, even blood testing is considered traditional and sensors are deployed for continuous monitoring.

Based on the patient care setting, the self/home care segment is going to have a huge demand owing to rising diabetic population, and increasing consciousness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home. By geography, North America is estimated to have a lucrative growth in the forecast period. The growth is mainly attributed by growing prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs.

Some of the key players profiled in the Blood Glucose Monitoring Systems Market include Abbott, Ascensia Diabetes Care Holdings AG, Braun Melsungen AG, Dexcom, Inc., DiamonTech GmbH, Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic, Terumo Medical Corporation, Ypsomed, Nipro, Sanofi, Arkray, Acon Laboratories and Prodigy Diabetes Care.

Types Covered:

  • Non-Invasive
  • Invasive

Modalities Covered:

  • Non- Wearable
  • Wearable

Distribution Channels Covered:

  • Retail Sales
  • Institutional Sales

Devices Covered:

  • Self-monitoring of Blood Glucose Monitoring Systems
  • Continuous Blood Glucose Monitoring Systems

Testing Sites Covered:

  • Alternate Site Testing
  • Fingertip testing

Patient Care Settings Covered:

  • Hospital & Clinics
  • Self/Home Care

Applications Covered:

  • Gestational Diabetes
  • Diabetes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blood Glucose Monitoring Systems Market, By Type

  • 5.1 Introduction
  • 5.2 Non-Invasive
  • 5.3 Invasive

6 Global Blood Glucose Monitoring Systems Market, By Modality

  • 6.1 Introduction
  • 6.2 Non- Wearable
  • 6.3 Wearable

7 Global Blood Glucose Monitoring Systems Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Sales
  • 7.3 Institutional Sales

8 Global Blood Glucose Monitoring Systems Market, By Device

  • 8.1 Introduction
  • 8.2 Self-monitoring of Blood Glucose Monitoring Systems
    • 8.2.1 Blood Glucose meters
    • 8.2.2 Lancets & Lancing Devices
    • 8.2.3 Testing strips
  • 8.3 Continuous Blood Glucose Monitoring Systems
    • 8.3.1 Receivers
    • 8.3.2 Sensors
    • 8.3.3 Transmitters

9 Global Blood Glucose Monitoring Systems Market, By Testing Site

  • 9.1 Introduction
  • 9.2 Alternate Site Testing
  • 9.3 Fingertip testing

10 Global Blood Glucose Monitoring Systems Market, By Patient Care Setting

  • 10.1 Introduction
  • 10.2 Hospital & Clinics
  • 10.3 Self/Home Care

11 Global Blood Glucose Monitoring Systems Market, By Application

  • 11.1 Introduction
  • 11.2 Gestational Diabetes
  • 11.3 Diabetes
    • 11.3.1 Type 1 Diabetes
    • 11.3.2 Type 2 Diabetes

12 Global Blood Glucose Monitoring Systems Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Abbott
  • 14.2 Ascensia Diabetes Care Holdings AG
  • 14.3 Braun Melsungen AG
  • 14.4 Dexcom, Inc.
  • 14.5 DiamonTech GmbH
  • 14.6 Hoffmann-La Roche Ltd.
  • 14.7 Lifescan Inc.
  • 14.8 Medtronic
  • 14.9 Terumo Medical Corporation
  • 14.10 Ypsomed
  • 14.11 Nipro
  • 14.12 Sanofi
  • 14.13 Arkray
  • 14.14 Acon Laboratories
  • 14.15 Prodigy Diabetes Care